Literature DB >> 12127169

Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?

Donald L Bliwise1.   

Abstract

Alzheimer's disease (AD) is acknowledged to be at least partially genetic, and one of the key genotypic markers for this condition is the APOE4 allele. Links between sleep apnea and AD have long been suspected because of mental impairment seen in some sleep apnea patients and possible evidence suggesting higher rates of sleep apnea in some dementia patients. The recent demonstration of an association between the APOE4 genotype and sleep apnea has rekindled further interest in this topic, particularly because sleep apnea is characterized by multiple genetic vulnerabilities. We review here evidence related to associations between sleep apnea and dementia, the role of APOE4 as a likely marker for cerebrovascular disease, and discuss treatment considerations relevant to sleep apnea as a potentially reversible cause of dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127169     DOI: 10.1016/s0022-3999(02)00436-1

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  25 in total

1.  Diagnosing And Treating Co-Morbid Sleep Apnea In Neurological Disorders.

Authors:  Erik K St Louis
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2010-07-01

2.  Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.

Authors:  Pamela L Lutsey; Jeffrey R Misialek; Thomas H Mosley; Rebecca F Gottesman; Naresh M Punjabi; Eyal Shahar; Richard MacLehose; Rachel P Ogilvie; David Knopman; Alvaro Alonso
Journal:  Alzheimers Dement       Date:  2017-07-21       Impact factor: 21.566

3.  Evaluation of the PHQ-9 Item 3 as a screen for sleep disturbance in primary care.

Authors:  Kristin L MacGregor; Jennifer S Funderburk; Wilfred Pigeon; Stephen A Maisto
Journal:  J Gen Intern Med       Date:  2011-09-24       Impact factor: 5.128

Review 4.  Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis.

Authors:  Yue Leng; Claire T McEvoy; Isabel E Allen; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 5.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

6.  Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults.

Authors:  Olivier Potvin; Dominique Lorrain; Hélène Forget; Micheline Dubé; Sébastien Grenier; Michel Préville; Carol Hudon
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

7.  Alzheimer's disease, sleep apnea, and positive pressure therapy.

Authors:  Donald L Bliwise
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

Review 8.  Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review.

Authors:  B Guarnieri; M Musicco; P Caffarra; F Adorni; I Appollonio; D Arnaldi; A Bartoli; E Bonanni; U Bonuccelli; C Caltagirone; G Cerroni; L Concari; F I I Cosentino; S Fermi; R Ferri; G Gelosa; G Lombardi; S Mearelli; F Nobili; S Passero; R Perri; R Rocchi; P Sucapane; G Tognoni; S Zabberoni; S Sorbi
Journal:  Neurol Sci       Date:  2014-07-19       Impact factor: 3.307

9.  Diagnosing and Treating Co-morbid Sleep Apnea in Neurological Disorders, Part II.

Authors:  Erik K St Louis
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2010-09

10.  Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population.

Authors:  Weihua Yue; Huiguo Liu; Jishui Zhang; Xianghui Zhang; Xiaoping Wang; Tieqiao Liu; Pozi Liu; Wei Hao
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.